Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Travere Therapeutics (TVTX)
NASDAQ:TVTX
Holding TVTX?
Track your performance easily
See the Price Targets and Ratings of:
TVTX Analyst Ratings
Strong Buy
11 Buy
3 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
TVTX Stock 12 Month Forecast
Average Price Target
$18.08
▲(18.87% Upside)
| Highest Price Target$25.00 | Average Price Target$18.08 | Lowest Price Target$10.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
J.P. Morgan
Reiterated
09/12/24
Guggenheim
Upgraded
09/09/24
Canaccord Genuity
Reiterated
09/09/24
Citi
Reiterated
09/06/24
Bank of America Securities
Reiterated
09/06/24
Wells Fargo
Assigned
09/06/24
Barclays
Assigned
09/06/24
H.C. Wainwright
Reiterated
09/06/24
Evercore ISI
Assigned
09/06/24
Stifel Nicolaus
Reiterated
09/06/24
Leerink Partners
$20
Buy
31.49%
Upside
Reiterated
09/05/24
Buy Rating Affirmed for Travere Therapeutics Following Filspari's Expanded FDA Approval and Positive Market Outlook
Piper Sandler
$12
Hold
-21.10%
Downside
Assigned
08/28/24
Piper Sandler Remains a Hold on Travere Therapeutics (TVTX)
Wedbush
$16
Buy
5.19%
Upside
Reiterated
08/02/24
Travere Therapeutics (TVTX) PT Raised to $16 at WedbushWedbush analyst Laura Chico raised the price target on Travere Therapeutics (NASDAQ: TVTX) to $16.00 (from $13.00) while maintaining a Outperform rating.
TD Cowen
$15
Buy
-1.38%
Downside
Assigned
08/02/24
Travere Therapeutics Poised for Continued Growth: A Buy Rating Based on Strong Financials and Market Potential
William Blair
―
Hold
―
Reiterated
05/28/24
William Blair reiterates Market Perform Rating on Travere Therapeutics (TVTX)William Blair analyst Tim Lugo reiterated a Market Perform rating on Travere Therapeutics (NASDAQ: TVTX)
Best Analysts Covering Travere Therapeutics
Which Analyst Should I Follow If I Want to Buy TVTX and Sell After:
1 Month
xxx
Success Rate
10/14 ratings generated profit
Average Return
+7.60%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 71.43% of your transactions generating a profit, with an average return of +7.60% per trade.
3 Months
xxx
Success Rate
9/14 ratings generated profit
Average Return
+9.64%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 64.29% of your transactions generating a profit, with an average return of +9.64% per trade.
1 Year
Success Rate
14/23 ratings generated profit
Average Return
+14.93%
assigned a buy rating 3 months ago
Copying Liisa Bayko's trades and holding each position for 1 Year would result in 60.87% of your transactions generating a profit, with an average return of +14.93% per trade.
2 Years
xxx
Success Rate
14/23 ratings generated profit
Average Return
+14.19%
assigned a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 60.87% of your transactions generating a profit, with an average return of +14.19% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
TVTX Analyst Recommendation Trends
Rating
May 24
Jun 24
Jul 24
Aug 24
Sep 24
Strong Buy
11
11
9
12
18
Buy
1
1
0
2
5
Hold
6
5
4
2
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
18
17
13
16
27
Each month's total comprises the sum of three months' worth of ratings.
TVTX Financial Forecast
TVTX Stock Forecast FAQ
What is TVTX’s average 12-month price target, according to analysts?
Based on analyst ratings, Travere Therapeutics’s 12-month average price target is $18.08.
What is TVTX’s upside potential, based on the analysts’ average price target?
Travere Therapeutics has 18.87% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is TVTX a Buy, Sell or Hold?
Travere Therapeutics has a consensus rating of Strong Buy which is based on 11 buy ratings, 3 hold ratings and 0 sell ratings.
What is Travere Therapeutics’s price target?
The average price target for Travere Therapeutics is $18.08. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $25.00 ,the lowest forecast is $10.00. The average price target represents 18.87% Increase from the current price of $15.21.
The highest analyst price target is $25.00 ,the lowest forecast is $10.00. The average price target represents 18.87% Increase from the current price of $15.21.
What do analysts say about Travere Therapeutics?
Travere Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of TVTX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.